2013 American Transplant Congress
Risk Factors for Acute Rejection in Heart Transplanted Recipients
Department of Medicine, Devision of Nephrology, UCLA, Los Angeles, CA
Purpose: Heart transplantation is the standard treatment for patients with end-stage heart disease. In this study we tried to determine factors associated with rejection in…2013 American Transplant Congress
Boceprevir (BOC) Based Triple Therapy (TTx) for Hepatitis C Recurrence after Liver Transplantation: Six Month Results
Yale New Haven Transplantation Center, New Haven
Background: Experience with treatment for HCV recurrence in liver transplant recipients (LTRs) using pegylated interferon, ribavirin (PR) and protease inhibitors (PIs) is limited.Methods: Adult genotype…2013 American Transplant Congress
Do the Number and Titers of Donor Specific Antibodies Correlate to C4D Positivity and Clinical Outcomes?
University of Southern California, Los Angeles, CA
AMR is a significant contributor of graft loss. Detection of DSA and C4D in Peri Tubular Capillaries (C4d+) has improved our understanding of AMR. It…2013 American Transplant Congress
Kidney Transplantation in Prisoners: Perspectives of Transplant Centers in the United States
The 8th Amendment requires that prisoners be provided a system of access to medical care. The number of inmates with ESRD is rising and the…2013 American Transplant Congress
Cytometry Time of Flight (CyTOF) Analysis of Epstein Barr Virus-Specific T Cells in Pediatric Liver Transplant Recipients
Surgery, Stanford University School of Medicine, Stanford, CA
Post-transplant lymphoproliferative disorder (PTLD) continues to be a serious problem in clinical transplantation. PTLD represents a spectrum of abnormal lymphoproliferations but most originate in B…2013 American Transplant Congress
Intraportal Autoislet Cell Transplantation (IAT): Changes in Portal Pressure and Flow and Associated Clinical Outcomes
Surgery, University of MN, Mpls, MN
IAT tissue volume (TV) delivered into the portal venous system can be associated with acute portal hypertension. We analyzed the relationships between transplanted TV, portal…2013 American Transplant Congress
Reduction in Mycophenolate in Leukopenic Renal Transplant Patients Is Not Associated with Worse Transplant Outcomes at 1 Year and 3 Year Post-Transplant
Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA
Leukopenia is common in renal transplant recipients (RTRs), and is often managed by dose reduction of causative immunosuppressants, which may in turn increase the risk…2013 American Transplant Congress
Impact of Matching Frequency in Kidney Paired Donation
Introduction: Kidney Paired Donation (KPD) programs use algorithms to find cycles involving incompatible pairs, and chains, initiated with a non-directed donor. KPD programs generally match…2013 American Transplant Congress
Small Donor Size Adversely Impact Kidney Allograft Function Following Living Donor Kidney Transplant
Background: We wanted to assess the impact of donor size and donor to recipient size mismatch on kidney allograft function following living donor kidney transplant.Methods:…2013 American Transplant Congress
Effect of EGF and FSP1 Targeting of Nanoparticle Delivery of IL-10 and GM-CSF Following Acute Kidney Injury, The
Surgery, University of Illinois at Chicago, Chicago, IL; LNK Chemsolutions, Lincoln, NE
Study Purpose: Renal fibrosis is a failure of regenerative mechanisms; strategies aimed towards identifying suitable targets for fibrotic tissue may hold promise in mitigating or…
American Transplant Congress abstracts